Labcorp Drug Development Revenue and Competitors
Estimated Revenue & Valuation
- Labcorp Drug Development's estimated annual revenue is currently $750M per year.
- Labcorp Drug Development's estimated revenue per employee is $80,394
Employee Data
- Labcorp Drug Development has 9329 Employees.
- Labcorp Drug Development grew their employee count by -32% last year.
Labcorp Drug Development's People
Name | Title | Email/Phone |
---|---|---|
1 | Executive Director, Business Development Early Development (Europe) | Reveal Email/Phone |
2 | Executive Director, Business Development | Reveal Email/Phone |
3 | Executive Director Business Development | Reveal Email/Phone |
4 | VP - Global Client Delivery | Reveal Email/Phone |
5 | VP, HR Partnering Clinical Trials Testing Solutions & Early Development | Reveal Email/Phone |
6 | Head Department | Reveal Email/Phone |
7 | SVP | Reveal Email/Phone |
8 | Head Sample Management and Archives | Reveal Email/Phone |
9 | VP, Global Regulatory Compliance & Quality Assurance - Central Laboratory Services | Reveal Email/Phone |
10 | Security Officer | Reveal Email/Phone |
What Is Labcorp Drug Development?
N/A
Total Funding
9329
Number of Employees
$750M
Revenue (est)
-32%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Labcorp Drug Development News
2022-04-20 - Labcorp beefs up at-home testing options with Getlabs' on ...
We actively use our QIAGEN biomedical knowledge graph in drug discovery projects in collaboration with industry partners and develop new...
2022-04-17 - Labcorp is teaming up with Xcell to expedite CGT development
The diagnostics and drug development company, Labcorp, is partnering with San Francisco based, Xcell Biosciences, to advance efforts to help...
2022-03-30 - Labcorp Renews Strategic Partnership with Medidata to ...
Labcorp Drug Development has developed its offerings on Medidata technologies, starting with Rave EDC (electronic data capture),...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2353.2M | 9338 | 7% | N/A |
#2 | $750M | 9485 | 6% | N/A |
#3 | $4371.2M | 9607 | -8% | N/A |
#4 | $3648.8M | 9653 | 5% | N/A |
#5 | N/A | 9716 | -2% | N/A |